1, Traditional small molecule drugs
(1)Tissue penetration: Usually very good;
(2)Binding: Usually contains distributions;
(3)Degradation: Metabolic degradation;
(4)Renal elimination: Usually very important;
(5)Free concentration: Thought to play a role in small molecule drug activity;
(6)Pharmacokinetics: Typically, linear; usually independent of pharmacodynamics.
2, Monoclonal antibody
(1)Tissue penetration: Usually weak;
(2)Binding: Usually involves clearance;
(3)Degradation: Hydrolytic degradation of proteins;
(4)Renal elimination: Rare;
(5)Free concentration: Thought to contribute to function and immunogenicity;
(6)Pharmacokinetics: Typically, nonlinear: usually dependent on pharmacodynamics and half-life of antigen x antibody (HAxA).